Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Sunday, September 1, 2024
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma

August 28, 2024
in Business
Reading Time: 3 mins read
A A
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
0
SHARES
ShareShareShareShareShare

Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma

Congress wants to reform a quasi-judicial tribunal that Big Tech firms have weaponized to attack their smaller rivals. Those Big Tech firms are rightfully worried that the reform legislation will prevent them from stealing smaller companies’ technologies without compensation and then exhausting the smaller firms with never-ending legal challenges at the tribunal.

Congress created the Patent Trial and Appeal Board in 2011 with good intentions. Lawmakers hoped it would be a faster, cheaper forum to resolve disputes about patent validity compared to the federal courts.

Unfortunately, Big Tech companies almost immediately weaponized the tribunal. After infringing the patents of less-established rivals, tech giants repeatedly challenge the underlying validity of those patents at the PTAB—while at the same time making the same challenges in federal court. They do this to wear down small inventors, who usually lack the resources to defend their IP against an onslaught of parallel and repetitive challenges. 

To fix this problem, Congress has introduced a bipartisan bill called the PREVAIL Act, which would crack down on abusive patent challenges and ban duplicative litigation at the PTAB and in federal court.

Opponents claim that PREVAIL will somehow raise drug prices by making it easier to defend pharmaceutical patents and block the introduction of cheaper generics. But given how few drug patents are challenged at all at the PTAB, it’s clear this argument is a stalking horse for Big Tech’s real concerns about the bill. Besides, PREVAIL does not prevent any defense against a patent—it just prevents the same defense from being made multiple times, which only serves to drain resources and weaken legitimate patents. 

Obviously, Big Tech lobbyists can’t advance a principled basis to defend intellectual property theft. “Let us keep stealing, it’s great!” is hardly a winning argument. So, instead, they’re trying to discredit the reform bill by arguing that it’ll lead to higher prescription drug costs. 

Fortunately, new data from the U.S. Patent and Trademark Office, which we both previously ran under Presidents Barack Obama and Donald Trump, debunks this myth. From September 2012 to March 2024, only 3% of all challenges at the tribunal involved patents covering brand-name pharmaceuticals. And just 2% of challenges involved patents for biologic drugs.

Simply put, the PTAB isn’t a significant battleground for drug patents. The vast majority of PTAB challenges involve electronics and computer technology. Strong patents catalyze innovation across virtually all high-tech industries. Lawmakers can’t allow falsehoods to sink PREVAIL. Passing this legislation is critical to ensure the U.S. remains competitive in areas like artificial intelligence, quantum computing, and engineering. Startups and small firms are often at the forefront of developing such technologies, but they’ll never succeed if corporate behemoths can plunder their ideas and bully them with repetitive litigation when they fight back.

If we let the U.S. patent system deteriorate, we risk relinquishing our place as a global technological leader, endangering U.S. economic competitiveness and national security.

PREVAIL would create a level playing field where small businesses have a fighting chance against established industry giants. To defend our geopolitical standing and economic prosperity, Congress should pass it immediately—and ignore false and misleading talking points.

More must-read commentary published by Fortune:

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Recommended reading:
In our new special issue, a Wall Street legend gets a radical makeover, a tale of crypto iniquity, misbehaving poultry royalty, and more.
Read the stories.

Credit: Source link

READ ALSO

Nvidia blows past expectations with record Q2 earnings but shares fall

Temu founder Colin Huang is no longer China’s richest man

ShareTweetSendSharePin
Previous Post

The best instant cameras for 2024

Next Post

Cryptocurrencies slide amid a wave of long liquidations, bitcoin briefly falls under $60,000

Related Posts

Nvidia blows past expectations with record Q2 earnings but shares fall
Business

Nvidia blows past expectations with record Q2 earnings but shares fall

August 29, 2024
Temu founder Colin Huang is no longer China’s richest man
Business

Temu founder Colin Huang is no longer China’s richest man

August 28, 2024
Lego has a historic half-year launching 300 new sets, opening 41 stores
Business

Lego has a historic half-year launching 300 new sets, opening 41 stores

August 28, 2024
What does Pavel Durov’s arrest mean for his tech legacy?
Business

What does Pavel Durov’s arrest mean for his tech legacy?

August 28, 2024
Lowe’s followed Tractor Supply, Harley Davidson and John Deere in backing off DEI initiatives
Business

Lowe’s followed Tractor Supply, Harley Davidson and John Deere in backing off DEI initiatives

August 28, 2024
Gen Z tackles frustrating job market
Business

Gen Z tackles frustrating job market

August 28, 2024
Next Post
Cryptocurrencies slide amid a wave of long liquidations, bitcoin briefly falls under ,000

Cryptocurrencies slide amid a wave of long liquidations, bitcoin briefly falls under $60,000

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

Mpox vaccine maker Bavarian Nordic seeks ‘critical’ approval for teens

Mpox vaccine maker Bavarian Nordic seeks ‘critical’ approval for teens

August 16, 2024
Paraguay swimmer Luana Alonso who was kicked out of Olympic Village over ‘inappropriate’ behavior wanted to compete for Team USA

Paraguay swimmer Luana Alonso who was kicked out of Olympic Village over ‘inappropriate’ behavior wanted to compete for Team USA

August 7, 2024
I’m from Japan what I drink every day for a long life

I’m from Japan what I drink every day for a long life

August 25, 2024
How homeowners insurance covers mold damage

How homeowners insurance covers mold damage

August 11, 2024
Aaron Rodgers does it all in one of his best day at Jets camp

Aaron Rodgers does it all in one of his best day at Jets camp

August 14, 2024
How Nerio Alessandri started Technogym in his parent’s garage and turned it into a billion-dollar company heading the Paris Olympics

How Nerio Alessandri started Technogym in his parent’s garage and turned it into a billion-dollar company heading the Paris Olympics

August 8, 2024
Racing legend Scott Bloomquist killed in plane crash

Racing legend Scott Bloomquist killed in plane crash

August 16, 2024

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • Jets’ Leonard Taylor III is living out NFL dream with assist from mom
  • LeBron James claps back at Caitlin Clark haters after her big night
  • The Pixel 9 phones are surprisingly great, in spite of their price
  • Against the spread college football picks, odds: Clemson-Georgia, Ohio-Syracuse, UCLA-Hawaii

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In